News

The patent includes both structure and method claims for inducing neurogenesis and the growth of new neurons, both in-vitro and in-vivo. Neuralstem announces Notice of Allowance for two

The data base will help hospitals improve their their cash flow and maintain better outcomes as they face shrinking reimbursements and escalating costs. The new VHA PriceLYNX 2.5

The technology is said to cater to the growing needs of retail pharmacies to proactively communicate with their customers by each customer’s preferred technology method, including phone call,

Antares’ Vibex platform includes Vibex MTX, an auto-injector which is in development and enables rheumatoid arthritis patients to comfortably and safely self-inject methotrexate at home. Vibex utilizes a

Roche said the newly developed analyzers will be marketed under Roche’s cobas brand and will include three platforms which will address a range of customer needs, from low-volume

Mymetics has provided license of its intra-nasal flu vaccine, under which Solvay has developed the vaccine until 2008 and also completed phase I trial. The results demonstrated that

The collaboration was made to develop two oncology targets involved in protein-protein interactions using Vernalis’ proprietary drug discovery platform. The research milestone allows the collaboration to be expanded

The facility is intended to target the global markets with antibody based drugs including Herceptin biosimilar. Dong-A and Japanese company, Meiji Seika Pharma signed an agreement to develop

ICT-107 is a dendritic cell-based vaccine which targets multiple tumor associated antigens for glioblastoma, for its Phase II clinical trial. Under the agreement, PCT will transfer and qualify